Page 16 - Rgene Technologies News Today : Breaking News, Live Updates & Top Stories | Vimarsana

LGBT+ Investment Firm Gaingels Joins American Gene Technologies' Mission to Cure HIV, and Other Serious Human Diseases News provided by Share this article , an emerging gene and cell therapy company, announced today that Gaingels, a leading venture investment syndicate in service of the LGBT+ community and its allies, made an investment in AGT to support the Phase 1 clinical trial of an HIV cure. The Phase 1 human trial is investigating the safety of AGT103-T, a single dose, autologous cell therapy intended to cure the disease. This investment places Gaingels alongside private investors who ...

Search jobs 01-Apr-2021 Global CRISPR and CRISPR-associated (Cas) Genes Market to 2026 with Profiles of OriGene Technologies, Thermo Fisher Scientific, Takara Bio, Horizon Discovery, Addgene and More - ResearchAndMarkets.com ResearchAndMarkets.com's offering. The CRISPR and CRISPR-associated (Cas) Genes Market was estimated to be USD 1,563.52 million in 2020 and is poised to grow at a CAGR of 15.67% to reach USD 3,733.66 million by the year 2026. The COVID-19 pandemic is expected to have a positive impact on the market due to an increase in demand ...

Published: Mar 12, 2021 Lonza to Commission a Dedicated Suite for Clinical and Commercial Supply of Altimmune’s COVID-19 Vaccine Candidate at its Houston Facility GAITHERSBURG, Md. and BASEL, Switzerland, March 12, 2021 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a clinical-stage biopharmaceutical company, today announced that it has expanded its previously-announced AdCOVID manufacturing collaboration with Lonza. Under the expanded agreement, Lonza will commission a dedicated manufacturing suite for clinical and commercial production of AdCOVID, Altimmune’s single-dose intran...

Share this article Share this article ResearchAndMarkets.com's offering. The Global Biochip Market is expected to grow at an impressive rate of around 15% during the forecast period. The Global Biochip Market is driven by the growing prevalence of various chronic and infectious disease especially in the geriatric population who are more susceptible to these diseases on account of low immunity. This has led to the increase in the demand for personalized medicine solutions or targeted therapies especially for treating diseases like cancer. This in turn is expected to positively influence the m...

 size is expected to reach USD 7.9 billion by 2028, according to a new report by Grand View Research, Inc. The market is expected to expand at a CAGR of 15.1% from 2021 to 2028. Technological advancements in viral vectors, a growing pipeline of advanced therapies, and a rising number of regulatory approvals for advance therapy products are some key driving forces of the market. Key suggestions from the report: The wide implementation of biological gene delivery technologies in clinical usage owing to their high efficiency and specificity has resulted in the segment's largest revenue share ...